Procter & Gamble (PG 0.33%) just gave investors some more reasons to like its stock this year. Management's mid-January earnings update contained good news regarding sales and earnings trends. The fiscal Q2 report showed that organic sales are on track to expand at a decent clip following big gains last year. Profits are rising at an even faster pace thanks to price increases along with the consumer staples giant's stellar operating efficiency.Those factors all suggest that P&G stock can beat the market in ...

Core Insights - Febreze has launched its third annual Scent of the Year, named Romance & Desire, aimed at enhancing connections among individuals in 2024 [1][2] - The scent combines pink rose petals and Champagne, designed to create an atmosphere of beauty, elegance, and intimacy [1][3] - The product is available in various forms, including air fresheners and plug-ins, with a price range of $3.29 to $9.99 [3] Company Overview - Febreze, launched by Procter & Gamble (P&G) in 1998, is recognized for its ability to provide fresh scents and eliminate tough odors [4] - The brand continues to grow rapidly within P&G's portfolio, focusing on innovative products that cater to consumer needs [4] - P&G operates in approximately 70 countries and offers a diverse range of trusted brands [5]

A whole new way to fight body odor. Native Whole Body Deodorant sprays and sticks deliver clinically proven 72-hour odor protection for your pits, privates, and more. (Photo: Business Wire)A whole new way to fight body odor. Native Whole Body Deodorant sprays and sticks deliver clinically proven 72-hour odor protection for your pits, privates, and more. (Photo: Business Wire)SAN FRANCISCO--(BUSINESS WIRE)--Native, the clean personal care brand, is proud to introduce its newest innovation and category extens ...

It turns out Procter & Gamble, the company which makes household staples like Tide detergent, Bounty paper towels, and Crest toothpaste, made more money last quarter because it raised prices on its household items, showing that even with inflation, people are still buying the company’s higher-priced products. During its latest quarterly earnings report on Tuesday (Jan. 23), the company also revealed that in addition to price hikes driving most of the sales growth, customers also purchased more items from P& ...

The Procter & Gamble Company (NYSE:PG) Q2 2024 Earnings Conference Call January 23, 2024 8:30 AM ET Company Participants Andre Schulten - CFO Jon Moeller - Chairman of the Board, President and CEO Jon Chevalier - SVP, IR Conference Call Participants Dara Mohsenian - Morgan Stanley Bryan Spillane - Bank of America Lauren Lieberman - Barclays Rob Ottenstein - Evercore ISI Steve Powers - Deutsche Bank Filippo Falorni - Citi Chris Carey - Wells Fargo Securities Andrea Teixeira - JPMorgan Peter Grom - UBS Jason ...

Core Insights - Procter & Gamble's Q2 FY2024 earnings and revenue missed analyst expectations, with revenue rising 3% year-over-year to $21.4 billion, primarily due to higher prices [1][3] - Net earnings fell 12% to $3.46 billion or $1.4 per diluted share, impacted by a $1.3 billion impairment charge related to the Gillette brand [1][2] - The impairment charge led to a reduction in P&G's FY2024 earnings projection, now expecting a 1% decline to in-line earnings compared to FY2023 EPS of $5.90, down from a previous estimate of 6% to 9% growth [2] Financial Performance - Revenue for Q2 FY2024 was $21.4 billion, slightly below analyst estimates of $21.6 billion, and up from $20.8 billion in Q2 FY2023, reflecting a 3% year-over-year increase [3] - Earnings per share (EPS) for Q2 FY2024 was $1.4, missing analyst expectations of $1.59, and down 12% from $1.59 in the same quarter last year [3] - Net income for the quarter was reported at $3.46 billion, compared to $4.2 billion in the previous quarter, marking a 12% decline year-over-year [3]

The Procter & Gamble Company (PG) has reported strong results in second-quarter fiscal 2024, wherein earnings surpassed the Zacks Consensus Estimate. Sales and earnings improved year over year. The company’s organic sales grew, driven by robust pricing, along with strength across segments.Procter & Gamble’s core earnings of $1.84 per share increased 16% from $1.59 in the year-ago quarter. The figure also beat the Zacks Consensus Estimate of $1.70. The strong bottom-line results have stemmed from improved sa ...

Procter & Gamble on Tuesday said sales of its high-end SK-II skincare brand fell 34% in the Greater China region during its latest quarter — and it blamed an unlikely culprit.With its high prices and reliance on travel retail, Japan-based SK-II has struggled as China's economic recovery lags. But P&G executives also pointed to another factor that contributed to the brand's cratering sales during the fiscal second quarter: anti-Japanese sentiment.In August, Japan started releasing a huge amount of treated ra ...

Cincinnati-based Procter & Gamble Co (NYSE:PG) is one of the first blue chips to kick off earnings season, beating profit expectations but missing on revenue for its fiscal second quarter. Annual outlook also took a hit, as the company did a write-down of its Gillette unit back in December. At last glance, PG is up 5.3% to trade at $155.67.On the charts Procter & Gamble stock has struggled to maintain stability, with yesterday's pullback captured by its 360-day moving average. The shares are clinging to a m ...

Procter & Gamble (PG) reported $21.44 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 3.2%. EPS of $1.84 for the same period compares to $1.59 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $21.55 billion, representing a surprise of -0.49%. The company delivered an EPS surprise of +8.24%, with the consensus EPS estimate being $1.70.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...